Inaccurate MDS Assessments for PASARR and Antipsychotic Medication
Summary
The facility failed to ensure the accurate completion of the Minimum Data Set (MDS) assessment under the Pre-Admission Screening and Resident Review (PASARR) for two residents and under the Antipsychotic Medication section for one resident. Resident 7 was admitted with diagnoses including schizophrenia and anxiety disorder. Despite having a PASARR Level II evaluation indicating a serious mental illness and requiring a structured environment and medication management, the MDS assessment inaccurately documented that the resident had not been evaluated by PASARR Level II. Additionally, the MDS assessment inaccurately documented that the resident had not received antipsychotic medications, despite records showing a prescription for olanzapine for schizophrenia. The MDS Coordinator admitted to completing the MDS without always having access to the paper chart, leading to these inaccuracies. Resident 41 was admitted with diagnoses including intellectual disabilities, schizophrenia, and major depressive disorder. The PASARR Level II Evaluation Report indicated a serious mental illness but no intellectual disability requiring specialized mental health services. However, the MDS assessment inaccurately documented that the resident had not been evaluated by PASARR Level II. The MDS Coordinator also admitted to not being aware of the PASARR Level II evaluation for this resident and completing the MDS without always having access to the paper chart, resulting in the inaccurate documentation.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.